5 Key Takeaways
-
1
AvKARE announced a voluntary recall of several ophthalmic products due to cGMP deviations identified by the FDA.
-
2
The recall was initiated by BRS Analytical Service, LLC, and affects products shipped between May 26, 2023, and April 21, 2025.
-
3
The FDA is aware of the recall, and further use of the affected products should cease immediately.
-
4
The health hazard to users is currently unknown, but cGMP deviations may lead to unacceptable product quality.
-
5
Consumers can find more details about the recalled products on AvKARE's website and the FDA's recall database.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.